ClinicalTrials.Veeva

Menu
S

SurGal Clinic | Gastroenterology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Mirikizumab
Risankizumab
Lutikizumab
JNJ-78934804

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis (DUET ENCORE-UC)

The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in par...

Enrolling
Colitis, Ulcerative
Drug: JNJ-78934804
Drug: Guselkumab

The purpose of this study is to evaluate safety and efficacy of risankizumab in participants with ulcerative colitis (UC) in participants who respond...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with...

Enrolling
Obesity or Overweight
Ulcerative Colitis
Drug: Mirikizumab
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administ...

Enrolling
Obesity or Overweight
Crohn's Disease
Drug: Placebo
Drug: Tirzepatide

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting...

Enrolling
Crohn's Disease
Drug: Trosunilimab
Drug: Risankizumab

Trial sponsors

AbbVie logo
Lilly logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems